Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony, -- Ignore unavailable to you. Want to Upgrade?

To: gbh who wrote (54960)	4/23/2000 4:21:00 PM
From: Anthony@Pacific	Read Replies (1) \| Respond to of 122087

That drug could have added approximately a max of 2 billion a year in revenues to a compnay that already does 20-22 billion the increase would have been nice but ..it certainly doenst warranta 30 billion dollar haircut/../ I have seen companies announce a 2 million dollar increase in revnue and seen the stocks run up more than a billion in mkt cap and yes all analysts are paid on stocks their firms are buying pre report and selling pre -downgrade..irrespective of what they publicly say..